Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Samuels JO"'
Publikováno v:
Babcock University Medical Journal; Vol. 6 No. 1 (2023); 17-31
Objective: High-risk behaviors among MSM have continually made this group susceptible to HIV and other STIs. Therefore, the study seeks to assess the prevalence of high-risk behaviors among MSM in Nigeria. Methodology: This quantitative descriptive c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::453c8e98a073ec0e2b29fec799601d66
https://www.ajol.info/index.php/bumj/article/view/246232
https://www.ajol.info/index.php/bumj/article/view/246232
Autor:
Samuels John
Publikováno v:
Marketing (Beograd. 1991), Vol 33, Iss 3-4, Pp 131-135 (2002)
The value of the total world market market research in the year 2001 was US$15,890 million, a 2.8% increase on the previous year. This is the first of several articles to be published in Research World on the results from ESOMAR's latest annual study
Externí odkaz:
https://doaj.org/article/59657847c64a46bdaab4f30fd7d65beb
Autor:
Ajayi OA; APIN Public Health Initiatives, Plot 1551, Zone E, Apo Resettlement, Apo, Abuja, Nigeria., Okonkwo P; Program Department, APIN Public Health Initiatives, Headquarter Office, Abuja, Nigeria., Ojo TO; Department of Community Health, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria., Ajayi OK; Community Medicine Department, University College Hospital, Ibadan, Nigeria., Ogunsola O; Prevention and Community Services, APIN Public Health Initiatives, Ibadan Office, Nigeria., Osayi E; Clinical Services, APIN Public Health Initiatives, Plateau Office, Nigeria., Onwuatuelo I; Program Department, APIN Public Health Initiatives, Headquarter Office, Abuja, Nigeria., Samuels JO; Program Department, APIN Public Health Initiatives, Headquarter Office, Abuja, Nigeria.
Publikováno v:
Therapeutic advances in infectious disease [Ther Adv Infect Dis] 2024 Oct 18; Vol. 11, pp. 20499361241289800. Date of Electronic Publication: 2024 Oct 18 (Print Publication: 2024).
Autor:
Madukaji L; APIN Public Health Initiatives Abuja, Nigeria., Okohu I; Bingham University Nigeria., Usman S; APIN Public Health Initiatives Abuja, Nigeria., Oyedum U; Federal University of Technology Minna, Nigeria., Enagi A; Federal University of Technology Minna, Nigeria., Usman A; Federal University of Technology Minna, Nigeria., Adedeji AS; Federal University of Technology Minna, Nigeria., Owolagba F; APIN Public Health Initiatives Abuja, Nigeria., Ofuche E; APIN Public Health Initiatives Abuja, Nigeria., Samuels JO; APIN Public Health Initiatives Abuja, Nigeria., Jolayemi T; APIN Public Health Initiatives Abuja, Nigeria., Okonkwo P; APIN Public Health Initiatives Abuja, Nigeria.
Publikováno v:
African health sciences [Afr Health Sci] 2021 Sep; Vol. 21 (3), pp. 968-974.
Autor:
Ogbenna AA; Department of Haematology and Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria., Meloni S; Department of Immunology and Infectious Disease, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., Inzaule S; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands., Hamers RL; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.; Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Sigaloff K; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, Amsterdam, Netherlands., Osibogun A; Department of Community Health and Primary Care, College of Medicine, Faculty of Clinical Sciences, University of Lagos, Lagos, Nigeria., Adeyemo TA; Department of Haematology and Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria., Okonkwo P; APIN Public Health Initiatives Ltd/Gte, Abuja, Nigeria., Samuels JO; APIN Public Health Initiatives Ltd/Gte, Abuja, Nigeria., Kanki PJ; Department of Immunology and Infectious Disease, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., Rinke de Wit TF; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands., Akanmu AS; Department of Haematology and Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
Publikováno v:
PloS one [PLoS One] 2020 Aug 25; Vol. 15 (8), pp. e0238027. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).
Autor:
Chaplin B; Department of Immunology & Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Akanmu AS; Department of Haematology and Blood Transfusion, College of Medicine of the University of Lagos, Lagos, Nigeria., Inzaule SC; Amsterdam Institute for Global Health and Development & Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands., Samuels JO; APIN Public Health Initiatives, Ltd/Gte, Abuja, Nigeria., Okonkwo P; APIN Public Health Initiatives, Ltd/Gte, Abuja, Nigeria., Ilesanmi O; World Health Organization, Abuja, Nigeria., Adewole IFA; Department of Obstetrics and Gynaecology, University of Ibadan, and the Federal Ministry of Health, Abuja, Nigeria., Asadu C; Federal Ministry of Health, Abuja, Nigeria., Khamofu H; FHI 360, Abuja, Nigeria., Mpazanje R; World Health Organization, Abuja, Nigeria., Ndembi N; Institute of Human Virology in Nigeria, Abuja, Nigeria., Odafe S; Centers for Disease Control and Prevention, Abuja, Nigeria., Sigaloff KCE; Amsterdam Institute for Global Health and Development & Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands., Ngige EN; Federal Ministry of Health, Abuja, Nigeria., Abatta EO; Federal Ministry of Health, Abuja, Nigeria., Akinbiyi G; Federal Ministry of Health, Abuja, Nigeria., Dakum P; Institute of Human Virology in Nigeria, Abuja, Nigeria., Rinke de Wit TF; Amsterdam Institute for Global Health and Development & Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands., Kanki P; Department of Immunology & Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jan 01; Vol. 74 (1), pp. 172-176.
Autor:
Hamel DJ; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United States., Sankalé JL; Globomics, LLC, Decatur, GA, United States., Samuels JO; AIDS Prevention Initiative in Nigeria Ltd. Gte., Abuja, Nigeria., Sarr AD; Global AIDS Program Malawi, Centers for Disease Control and Prevention, NICO House Lilongwe 3, Malawi., Chaplin B; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United States., Ofuche E; AIDS Prevention Initiative in Nigeria Ltd. Gte., Abuja, Nigeria., Meloni ST; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United States., Okonkwo P; AIDS Prevention Initiative in Nigeria Ltd. Gte., Abuja, Nigeria., Kanki PJ; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United States.
Publikováno v:
African journal of laboratory medicine [Afr J Lab Med] 2015; Vol. 4 (1). Date of Electronic Publication: 2015 May 14.